NO20014529L - Tetrahydropyranderivater og deres anvendelse som terapautiske midler - Google Patents

Tetrahydropyranderivater og deres anvendelse som terapautiske midler

Info

Publication number
NO20014529L
NO20014529L NO20014529A NO20014529A NO20014529L NO 20014529 L NO20014529 L NO 20014529L NO 20014529 A NO20014529 A NO 20014529A NO 20014529 A NO20014529 A NO 20014529A NO 20014529 L NO20014529 L NO 20014529L
Authority
NO
Norway
Prior art keywords
alkyl
hydroxy
alkoxy
fluoro
group
Prior art date
Application number
NO20014529A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014529D0 (no
Inventor
Simon Neil Owen
Eileen Mary Seward
Christopher John Swain
Brian John Williams
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906480.0A external-priority patent/GB9906480D0/en
Priority claimed from GBGB9924616.7A external-priority patent/GB9924616D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO20014529D0 publication Critical patent/NO20014529D0/no
Publication of NO20014529L publication Critical patent/NO20014529L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20014529A 1999-03-19 2001-09-18 Tetrahydropyranderivater og deres anvendelse som terapautiske midler NO20014529L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906480.0A GB9906480D0 (en) 1999-03-19 1999-03-19 Therapeutic agents
GBGB9924616.7A GB9924616D0 (en) 1999-10-18 1999-10-18 Therapeutic agents
PCT/GB2000/000977 WO2000056728A1 (en) 1999-03-19 2000-03-16 Tetrahydropyran derivatives and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
NO20014529D0 NO20014529D0 (no) 2001-09-18
NO20014529L true NO20014529L (no) 2001-11-13

Family

ID=26315315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014529A NO20014529L (no) 1999-03-19 2001-09-18 Tetrahydropyranderivater og deres anvendelse som terapautiske midler

Country Status (23)

Country Link
US (1) US6458830B1 (de)
EP (1) EP1165540B1 (de)
JP (1) JP2002540107A (de)
KR (1) KR20010113773A (de)
CN (1) CN1344264A (de)
AT (1) ATE247096T1 (de)
AU (2) AU3304400A (de)
BG (1) BG105859A (de)
BR (1) BR0009127A (de)
CA (1) CA2367985A1 (de)
CO (1) CO5150225A1 (de)
CZ (1) CZ20013377A3 (de)
DE (1) DE60004504T2 (de)
EA (1) EA200100902A1 (de)
EE (1) EE200100491A (de)
ES (1) ES2203434T3 (de)
HU (1) HUP0200441A3 (de)
IL (1) IL144236A0 (de)
NO (1) NO20014529L (de)
PE (1) PE20001556A1 (de)
PL (1) PL350123A1 (de)
SK (1) SK13322001A3 (de)
WO (2) WO2000056728A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001785A1 (de) * 2000-01-18 2001-07-19 Boehringer Ingelheim Pharma NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0020721D0 (en) 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
PE20020444A1 (es) 2000-09-22 2002-06-14 Merck & Co Inc Antagonistas de receptores de taquiquinina zwitterionica
US6906085B2 (en) 2001-01-17 2005-06-14 Merck Sharp & Dohme Ltd. Tetrahydropyran derivatives as neurokinin receptor antagonists
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (de) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-hemmer mit antioxidativer und no-donor-wirkung
EP1603901B1 (de) * 2003-03-07 2008-10-15 MERCK SHARP & DOHME LTD. Tetrahydropyranverbindungen als tachykininantagonisten
EP1791847A2 (de) * 2004-09-08 2007-06-06 Altana Pharma AG Neue 3-thia-10-aza-phenanthrenderivative
ATE429415T1 (de) * 2004-11-30 2009-05-15 Mallinckrodt Inc Verfahren zur kristallisierung von benzphetamin
EP1873153B1 (de) * 2005-04-22 2010-07-07 Daiichi Sankyo Company, Limited 3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva
CN100395242C (zh) * 2006-06-08 2008-06-18 华东理工大学 烷氧基萘和萘醌类吡喃碳糖苷化合物及其制备方法
DE102007010077B4 (de) * 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
DK2729147T3 (en) 2011-07-04 2017-12-18 Irbm - Science Park S P A NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF CORNOVA
CA2883791A1 (en) * 2012-09-04 2014-03-13 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof
CA2951259A1 (en) 2014-06-06 2015-12-10 Flexus Biosciences, Inc. Immunoregulatory agents
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
JP2017538678A (ja) * 2014-11-05 2017-12-28 フレクサス・バイオサイエンシーズ・インコーポレイテッドＦｌｅｘｕｓ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． 免疫調節剤
HU231150B1 (hu) 2017-03-13 2021-03-29 Richter Gedeon Nyrt Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására
CA3090453C (en) * 2018-02-06 2022-05-31 Daiichi Sankyo Company, Limited Aminoalkyl compound
US20210015834A1 (en) 2018-02-26 2021-01-21 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
EP4117673A1 (de) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Behandlung von stammzellenmangel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301920D0 (en) * 1993-02-01 1993-03-17 Foundation For Ethnobiology Th Polycetylenes

Also Published As

Publication number Publication date
AU746251B2 (en) 2002-04-18
HUP0200441A2 (hu) 2002-07-29
HUP0200441A3 (en) 2002-09-30
US6458830B1 (en) 2002-10-01
KR20010113773A (ko) 2001-12-28
PL350123A1 (en) 2002-11-04
CZ20013377A3 (cs) 2002-02-13
JP2002540107A (ja) 2002-11-26
DE60004504D1 (de) 2003-09-18
WO2000056728A1 (en) 2000-09-28
SK13322001A3 (sk) 2002-02-05
EP1165540B1 (de) 2003-08-13
EP1165540A1 (de) 2002-01-02
EE200100491A (et) 2002-12-16
BG105859A (bg) 2002-04-30
ATE247096T1 (de) 2003-08-15
AU3304200A (en) 2000-10-09
BR0009127A (pt) 2001-12-26
DE60004504T2 (de) 2004-06-24
CO5150225A1 (es) 2002-04-29
IL144236A0 (en) 2002-05-23
CN1344264A (zh) 2002-04-10
EA200100902A1 (ru) 2002-02-28
AU3304400A (en) 2000-10-09
CA2367985A1 (en) 2000-09-28
WO2000056727A1 (en) 2000-09-28
PE20001556A1 (es) 2001-01-13
ES2203434T3 (es) 2004-04-16
NO20014529D0 (no) 2001-09-18

Similar Documents

Publication Publication Date Title
NO20014529L (no) Tetrahydropyranderivater og deres anvendelse som terapautiske midler
BRPI0110955B8 (pt) derivados de tropano composição farmacêutica, uso dos mesmos na fabricação de um medicamento bem como processo para a preparação dos mesmos.
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20060459A1 (es) DERIVADOS DE AMINO-5,5-DIFENILIMIDAZOLONA COMO INHIBIDORES DE LA ß-SECRETASA
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
NO331068B1 (no) Benzazepinderivater for behandling av nevrologiske forstyrrelser.
NO20062704L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
NO20083917L (no) Malonamidderivater som gammasekretaseinhibitorer
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
NO20090270L (no) Cinnamoyl-piperazinederivater og deres anvendelse som PAR-I-antagonister
AR082075A1 (es) Derivados de dioxima eter microbicidas
TR199902495T2 (xx) Bile�imler.
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20033959L (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
ATE270550T1 (de) Wirkstoff zum schutz für organ oder gewebe
AR056321A1 (es) COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
CO5660261A2 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion de estos y usos de estos
NO20080816L (no) Anvendelse av delmopinol ved behandling av kviser
PE25998A1 (es) DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application